Neurogene Inc. (NASDAQ:NGNE) Receives $51.00 Consensus PT from Analysts

Shares of Neurogene Inc. (NASDAQ:NGNE – Get Free Report) have been given a consensus recommendation of “Buy” by the nine research firms that are covering the firm, Marketbeat.com reports. Eight analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month target price […]

Leave a Reply

Your email address will not be published.

Previous post Today in History: October 30, Muhammad Ali defeats George Foreman in the “Rumble in the Jungle”
Next post Mueller Water Products, Inc. (NYSE:MWA) Given Consensus Rating of “Hold” by Brokerages